D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
JNCE holding history
Jounce Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
JNCE overviewAll 13F holders of JNCEFull Q2 2026 holdings
- Shares (Q3 2022)
- 0
- Sold out in Q3 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 0 | $0 | 0.0% | −52,462−100.0% | Sold out | Holders |
| Q2 2022 | 52,462 | $159.0K | <0.1% | +52,462 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −68,776−100.0% | Sold out | Holders |
| Q4 2021 | 68,776 | $574.0K | <0.1% | +34,388+100.0% | Added | Holders |
| Q3 2021 | 34,388 | $256.0K | <0.1% | −44,535−56.4% | Reduced | Holders |
| Q2 2021 | 78,923 | $537.0K | <0.1% | +78,923 | New | Holders |